Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome
NCT ID: NCT00559390
Last Updated: 2013-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
136 participants
OBSERVATIONAL
2006-07-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
NCT00364949
Blood Vessel Function in Adolescents and Women With Polycystic Ovary Syndrome
NCT01615562
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
NCT01482286
The Genetics of Polycystic Ovarian Syndrome
NCT00166569
The Study of Polycystic Ovary Syndrome(PCOS) With Gene and Questionnaire
NCT01114659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-PCOS
First degree relatives, either sisters or daughters, of women with Polycystic Ovary Syndrome.
No interventions assigned to this group
Controls
Sisters and daughters of women who do not have PCOS
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No relatives with polycystic ovary syndrome
* Overweight
* White non-hispanic girls
Exclusion Criteria
* Smokers
* Already having periods
8 Years
12 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Northwestern Memorial Hospital
OTHER
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Dunaif
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Dunaif, MD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University, Chicago, IL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Urbanek M, Sam S, Legro RS, Dunaif A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab. 2007 Nov;92(11):4191-8. doi: 10.1210/jc.2007-0761. Epub 2007 Sep 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DK73411
Identifier Type: -
Identifier Source: secondary_id
0956-023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.